Quant Healthcare Fund Overview | ||||||
---|---|---|---|---|---|---|
Category | Pharma Fund | |||||
BMSMONEY Rank | N/A | |||||
BMSMONEY Rating | N/A | |||||
Gro. Opt. | As On: | 20-12-2024 | ||||
NAV | ₹15.41(R) | -2.09% | ₹15.78(D) | -2.08% | ||
Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
LumpSum (R) | 33.84% | -% | -% | -% | -% | |
LumpSum (D) | 36.04% | -% | -% | -% | -% | |
SIP (R) | -35.24% | -% | -% | -% | -% | |
SIP (D) | -34.0% | -% | -% | -% | -% | |
Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
NAV Date: 20-12-2024
Scheme Name | NAV | Rupee Change | Percent Change |
---|---|---|---|
quant Healthcare Fund - Growth Option - Regular Plan | 15.41 |
-0.3300
|
-2.0900%
|
quant Healthcare Fund - IDCW Option - Regular Plan | 15.41 |
-0.3300
|
-2.0900%
|
quant Healthcare Fund - Growth Option - Direct Plan | 15.78 |
-0.3400
|
-2.0800%
|
quant Healthcare Fund - IDCW Option - Direct Plan | 15.78 |
-0.3400
|
-2.0800%
|
Review Date: 20-12-2024
A review of the different performance parameters of the fund is as follows:KPIs* | Fund | Benchmark | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
---|---|---|---|---|---|---|
1M Return % | -0.97 |
2.88
|
-0.97 | 4.52 | 13 | 13 | Poor | |
3M Return % | -9.73 |
-0.40
|
-9.73 | 3.09 | 13 | 13 | Poor | |
6M Return % | 3.40 |
19.11
|
3.40 | 26.27 | 13 | 13 | Poor | |
1Y Return % | 33.84 |
42.49
|
33.84 | 51.93 | 12 | 12 | Poor | |
1Y SIP Return % | -35.24 |
-21.85
|
-35.24 | -12.91 | 12 | 12 | Poor |
KPIs* | Fund | Benchmark | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
---|---|---|---|---|---|---|
1M Return % | -0.84 | 2.99 | -0.84 | 4.64 | 13 | 13 | ||
3M Return % | -9.36 | -0.08 | -9.36 | 3.54 | 13 | 13 | ||
6M Return % | 4.26 | 19.88 | 4.26 | 27.36 | 13 | 13 | ||
1Y Return % | 36.04 | 44.30 | 36.04 | 53.85 | 12 | 12 | ||
1Y SIP Return % | -34.00 | -20.75 | -34.00 | -11.70 | 12 | 12 |
Investment Period | Regular | Direct | ||
---|---|---|---|---|
Return % | Current Value of ₹ 10000 | Return % | Current Value of ₹ 10000 | |
1D | -2.09 | ₹ 9,791.00 | -2.08 | ₹ 9,792.00 |
1W | -2.71 | ₹ 9,729.00 | -2.67 | ₹ 9,733.00 |
1M | -0.97 | ₹ 9,903.00 | -0.84 | ₹ 9,916.00 |
3M | -9.73 | ₹ 9,027.00 | -9.36 | ₹ 9,064.00 |
6M | 3.40 | ₹ 10,340.00 | 4.26 | ₹ 10,426.00 |
1Y | 33.84 | ₹ 13,384.00 | 36.04 | ₹ 13,604.00 |
3Y | ₹ | ₹ | ||
5Y | ₹ | ₹ | ||
7Y | ₹ | ₹ | ||
10Y | ₹ | ₹ | ||
15Y | ₹ | ₹ |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
Investment Period | Invested Amount | Regular | Direct | ||
---|---|---|---|---|---|
XIRR % | Current Value of Invested Amount | XIRR % | Current Value of Invested Amount | ||
1Y | ₹ 12000 | -35.24 | ₹ 9,559.61 | -34.00 | ₹ 9,651.49 |
3Y | ₹ 36000 | ₹ | ₹ | ||
5Y | ₹ 60000 | ₹ | ₹ | ||
7Y | ₹ 84000 | ₹ | ₹ | ||
10Y | ₹ 120000 | ₹ | ₹ | ||
15Y | ₹ 180000 | ₹ | ₹ |
Date | Quant Healthcare Fund NAV Regular Growth | Quant Healthcare Fund NAV Direct Growth |
---|---|---|
20-12-2024 | 15.4126 | 15.7786 |
19-12-2024 | 15.7414 | 16.1145 |
18-12-2024 | 15.6956 | 16.0668 |
17-12-2024 | 15.693 | 16.0635 |
16-12-2024 | 15.9079 | 16.2827 |
13-12-2024 | 15.8413 | 16.2122 |
12-12-2024 | 15.8976 | 16.2692 |
11-12-2024 | 16.1075 | 16.4832 |
10-12-2024 | 16.0853 | 16.4597 |
09-12-2024 | 16.0792 | 16.4527 |
06-12-2024 | 16.2216 | 16.5961 |
05-12-2024 | 16.2134 | 16.587 |
04-12-2024 | 16.307 | 16.6819 |
03-12-2024 | 16.3398 | 16.7147 |
02-12-2024 | 16.3681 | 16.7429 |
29-11-2024 | 16.2819 | 16.6524 |
28-11-2024 | 16.0864 | 16.4517 |
27-11-2024 | 15.9961 | 16.3585 |
26-11-2024 | 15.8287 | 16.1866 |
25-11-2024 | 15.8311 | 16.1883 |
22-11-2024 | 15.6874 | 16.0392 |
21-11-2024 | 15.5634 | 15.9116 |
Fund Launch Date: 17/Jul/2023 |
Fund Category: Pharma Fund |
Investment Objective: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends. |
Fund Description: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends. |
Fund Benchmark: BSE Healthcare TRI |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.